Clinical Trial Update: Etoricoxib in Acute Soft Tissue Rheumatism Affecting the Shoulder [Phase 3]

View source ↗

Summary

Phase 3 trial of etoricoxib for acute soft tissue injuries of the shoulder has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bursitis of the Shoulder
• Soft Tissue Injuries of the Shoulder
• Tenosynovitis of the Shoulder

Drugs mentioned

• Arcoxia (Etoricoxib)

Snippet

Sponsor: Clinica Virgen Milagrosa | Conditions: Soft Tissue Injuries of the Shoulder, Tenosynovitis and Bursitis Affecting the Shoulder | Phase 3 | Status: TERMINATED